Physiologic mitochondrial and cellular metabolic processes

Physiologic mitochondrial and cellular metabolic processes refer to the integrated network of biochemical reactions that sustain life by converting nutrients into energy and biosynthetic precursors. At the core of these processes is the mitochondrion, which generates the majority of cellular adenosine triphosphate (ATP) through the tricarboxylic acid (TCA) cycle and the electron transport chain (ETC) [Source: NIH, StatPearls]. Beyond bioenergetics, these processes are vital for maintaining redox balance, regulating apoptosis, and managing intracellular calcium levels [Source: Nature Reviews Molecular Cell Biology]. Dysregulation of these metabolic pathways is central to the pathogenesis of diverse conditions, including metabolic syndrome, neurodegeneration, and cancer, where metabolic reprogramming allows cells to adapt to environmental stress [Source: Cell Metabolism]. While these processes are not a single molecular target, many therapeutic agents act by modulating specific enzymes or transporters within these pathways, such as Metformin's inhibition of mitochondrial Complex I to treat type 2 diabetes [Source: PubMed]. However, targeting these fundamental processes carries significant risks, as systemic disruption can lead to mitochondrial toxicity and multi-organ failure [Source: FDA].

Other names

Mitochondrial metabolismCellular respirationBioenergeticsEnergy metabolismIntermediary metabolism

Drugs typically modulate specific components of these processes, such as inhibiting electron transport chain complexes (e.g., Metformin on Complex I), uncoupling oxidative phosphorylation, or altering substrate availability for the TCA cycle [Source: PubMed: 24929250, StatPearls].